Formula: | C21H22FN3 |
Molecular Weight: | 335.43 |
Rotatable Bond Donors: | 3 |
clogP: | 4.69 |
Topological Polar Surface Area: | 31.92 |
Lipinski's RO5: | MW: 335.43 HBA: 3 HBD: 1 RB: 3 LogP: 4.69 |
Rule of Three: | MW: 335.43 HBA: 3 HBD: 1 RB: 3 LogP: 4.69 |
|
DB |
---|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC9158 | 1.0 | ZINC9158 RDKit 3D 25 28 0 0 0 0 0 0 0 0999 V2000 6.8495 0.7803 -1.8521 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4621 0.7407 -1.4257 N 0 0 0 0 0 0 0 0 0 0 0 0 4.6493 0.6471 -2.6314 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1796 0.6002 -2.2652 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9007 -0.5699 -1.3447 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4913 -0.5967 -0.9038 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5072 -1.5313 -1.1168 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6785 -1.0862 -0.4657 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.9427 -1.7940 -0.4025 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6370 -1.9155 0.7988 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.8165 -2.6411 0.7981 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3306 -3.2496 -0.2921 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.6222 -3.1285 -1.4355 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4333 -2.4264 -1.5423 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3975 0.1543 0.1062 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2058 1.1430 0.8194 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6208 1.9701 1.7853 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3739 2.9318 2.4547 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7219 3.0721 2.1479 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.4513 3.9948 2.7894 F 0 0 0 0 0 0 0 0 0 0 0 0 -3.3248 2.2718 1.1852 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5613 1.3139 0.5222 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9311 0.3961 -0.1558 N 0 0 0 0 0 0 0 0 0 0 0 0 3.8574 -0.5950 -0.1707 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2897 -0.4822 -0.6525 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 1 0 4 5 1 0 5 6 1 0 6 7 2 0 7 8 1 0 8 9 1 0 9 10 2 0 10 11 1 0 11 12 2 0 12 13 1 0 13 14 2 0 8 15 2 0 15 16 1 0 16 17 2 0 17 18 1 0 18 19 2 0 19 20 1 0 19 21 1 0 21 22 2 0 15 23 1 0 5 24 1 0 24 25 1 0 25 2 1 0 23 6 1 0 14 9 1 0 22 16 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |